ストックスクリーナーアプリを入手
578.71
0.24%
-1.42
アフターアワーズ：
578.71
前日終値:
$580.13
開ける：
$578.185
24時間の取引高:
1.32M
Relative Volume:
0.65
時価総額：
$218.53B
収益：
$43.74B
当期純損益:
$6.58B
株価収益率:
33.44
EPS:
17.3072
ネットキャッシュフロー:
$6.11B
1週間 パフォーマンス:
+1.10%
1か月 パフォーマンス:
+10.06%
6か月 パフォーマンス:
+42.52%
1年 パフォーマンス:
+8.57%
1日の値動き範囲:
$573.00
$584.33
1週間の範囲:
$568.36
$598.51
52週間の値動き範囲:
$385.46
$610.97
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
名前
Thermo Fisher Scientific Inc
セクター
電話
(781) 622-1000
住所
168 THIRD AVENUE, WALTHAM, MA
TMO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
578.71 | 217.96B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
221.21 | 156.24B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
689.93 | 56.01B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
146.82 | 41.64B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
220.61 | 38.07B | 15.90B | 1.28B | 2.21B | 7.2842 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-11 | アップグレード | Barclays | Equal Weight → Overweight |
| 2025-08-19 | 開始されました | William Blair | Outperform |
| 2025-07-24 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-07-11 | アップグレード | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | ダウングレード | UBS | Buy → Neutral |
| 2025-01-10 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 開始されました | Scotiabank | Sector Perform |
| 2024-10-14 | 開始されました | Redburn Atlantic | Buy |
| 2024-10-01 | 開始されました | Stephens | Overweight |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-03-18 | 再開されました | Citigroup | Neutral |
| 2024-01-24 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2024-01-08 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | 開始されました | HSBC Securities | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-10-26 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-09-06 | 再開されました | Citigroup | Buy |
| 2023-07-19 | 開始されました | Raymond James | Outperform |
| 2023-07-19 | 繰り返されました | Robert W. Baird | Outperform |
| 2023-07-13 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | 繰り返されました | Barclays | Overweight |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-10-27 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 開始されました | Credit Suisse | Neutral |
| 2022-04-25 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | 再開されました | Barclays | Overweight |
| 2021-10-20 | アップグレード | Citigroup | Neutral → Buy |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-16 | 開始されました | The Benchmark Company | Buy |
| 2021-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 開始されました | Barclays | Overweight |
| 2021-01-08 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-12-02 | 開始されました | Goldman | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-14 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-20 | 再開されました | JP Morgan | Overweight |
| 2020-07-15 | アップグレード | Cleveland Research | Neutral → Buy |
| 2020-07-07 | 繰り返されました | Needham | Buy |
| 2020-04-23 | 繰り返されました | Needham | Buy |
| 2020-01-31 | 繰り返されました | Needham | Buy |
| 2020-01-22 | 開始されました | Credit Suisse | Neutral |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-07-25 | 繰り返されました | Needham | Buy |
| 2019-07-16 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-05-30 | 開始されました | Wolfe Research | Outperform |
| 2019-05-23 | 繰り返されました | Needham | Strong Buy |
| 2019-04-22 | 繰り返されました | Needham | Strong Buy |
| 2019-04-16 | 繰り返されました | BofA/Merrill | Buy |
すべてを表示
Thermo Fisher Scientific Inc (TMO) 最新ニュース
Is Thermo Fisher Scientific Inc. (TN8) stock considered safe havenJuly 2025 News Drivers & High Conviction Buy Zone Picks - newser.com
Is Thermo Fisher Scientific Inc. (TN8) stock supported by strong fundamentalsWeekly Earnings Recap & Real-Time Stock Price Movement Reports - newser.com
How Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock gains from tech spendingJuly 2025 Snapshot & Free Technical Pattern Based Buy Signals - newser.com
How robust is Thermo Fisher Scientific Inc stock financial positionAnalyst Upgrade & Community Verified Watchlist Alerts - newser.com
Insider Sell: Lisa Britt Sells Shares of Thermo Fisher Scientifi - GuruFocus
Will Thermo Fisher Scientific Inc stock outperform benchmarks2025 Top Decliners & Safe Swing Trade Setups - newser.com
Rx Rundown: Metagenomi, Chiesi, Thermo Fisher Scientific and more - Medical Marketing and Media
Thermo Fisher Scientific Insider Sold Shares Worth $2,756,920, According to a Recent SEC Filing - MarketScreener
Will Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock hit analyst forecastsEarnings Overview Summary & Real-Time Chart Pattern Alerts - newser.com
Why Thermo Fisher Scientific Inc. (TN8) stock remains top ratedTrade Signal Summary & Risk Controlled Stock Alerts - Fundação Cultural do Pará
The Zacks Analyst Blog Highlights NVIDIA, Micron Technology and Thermo Fisher Scientific - Nasdaq
If You Invested $1000 in Thermo Fisher Scientific 10 Years Ago, This Is How Much You'd Have Now - Yahoo Finance
Kimberly-Clark, Thermo Fisher Scientific, Berkshire Hathaway And An Industrial Stock On CNBC's 'Final Trades' - Benzinga
Will Thermo Fisher Scientific Inc. stock recover faster than peersQuarterly Earnings Report & Verified Trade Idea Suggestions - newser.com
Thermo Fisher Scientific (TMO): Assessing Valuation After a 10% Monthly Share Price Surge - Yahoo Finance
How dovish Fed policy supports Thermo Fisher Scientific Inc. (TN8) stock2025 Geopolitical Influence & Reliable Volume Spike Alerts - newser.com
Why Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock signals breakout potentialWeekly Profit Analysis & Consistent Growth Equity Picks - newser.com
Is Thermo Fisher Scientific Inc. (TN8) stock among top earnings playsJuly 2025 EndofMonth & Intraday High Probability Alerts - newser.com
Fund Update: 127,576 THERMO FISHER SCIENTIFIC (TMO) shares added to First Pacific Advisors, LP portfolio - Quiver Quantitative
Top Research Reports for NVIDIA, Micron Technology & Thermo Fisher - Yahoo Finance
Why analysts recommend Thermo Fisher Scientific Inc. (Common Stock) (TN80) stockJuly 2025 Momentum & Consistent Profit Alerts - newser.com
Will Thermo Fisher Scientific Inc. (TN8) stock split increase liquidityMarket Movement Recap & Risk Controlled Stock Alerts - newser.com
Can Thermo Fisher Scientific Inc stock attract ESG investmentsWeekly Trade Recap & Fast Moving Market Watchlists - newser.com
Are Wall Street Analysts Predicting Thermo Fisher Scientific Stock Will Climb or Sink? - Barchart.com
Thermo Fisher Scientific Receives 510(k) Clearance in the United States for EXENT System* to Aid in the Diagnosis of Multiple Myeloma - BioSpace
Visual analytics tools that track Thermo Fisher Scientific Inc. performanceQuarterly Portfolio Report & Expert Curated Trade Setups - newser.com
Will Thermo Fisher Scientific Inc. (TN8) stock sustain bullish trend into 2025Take Profit & Verified Momentum Stock Ideas - newser.com
Finalists in the Thermo Fisher JIC explore biomimicry with SERC - societyforscience.org
Thermo Fisher Scientific Receives 510(K) Clearance in the United States for EXENT System to Aid in the Diagnosis of Multiple Myeloma - MarketScreener
Thermo Fisher Scientific Says US FDA Clears Exent System for Multiple Myeloma Diagnosis - MarketScreener
Thermo Fisher’s new diagnostic system for multiple myeloma gets FDA clearance - Investing.com India
Thermo Fisher (NYSE: TMO) receives FDA 510(k) for EXENT M-protein detection for myeloma - Stock Titan
Why analysts remain bullish on Thermo Fisher Scientific Inc. stock2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - newser.com
Should Thermo Fisher's (TMO) New $5 Billion Buyback Change Views on Its Capital Allocation Priorities? - simplywall.st
Is Thermo Fisher Scientific Inc stock in buy zone after pullback2025 Historical Comparison & AI Forecasted Entry/Exit Points - newser.com
Why Thermo Fisher Scientific Inc. stock is rated strong buyJuly 2025 Opening Moves & Expert Verified Stock Movement Alerts - newser.com
Thermo Fisher (TMO) sr. VP Britt sells $5.8 million in stock - Investing.com India
Thermo Fisher Scientific Insider Sold Shares Worth $5,844,850, According to a Recent SEC Filing - MarketScreener
Implied Volatility Surging for Thermo Fisher Stock Options - Yahoo Finance
Thermo Fisher Scientific Inc. recovery potential after sell offWeekly Profit Report & Daily Volume Surge Trade Alerts - newser.com
Gene Expression Market Forecast 2025-2032: Emerging Trends, - openPR.com
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 20 Years - Sahm
Thermo Fisher Scientific (TMO): Evaluating Valuation After $5 Billion Share Buyback Announcement - simplywall.st
Thermo Fisher (TMO) Announces $5 Billion Share Buyback Plan - GuruFocus
Thermo Fisher Unveils $5 Billion Buyback, Keeps Dividend Intact - GuruFocus
Published on: 2025-11-07 08:49:17 - newser.com
Thermo Fisher Scientific Inc.'s (NYSE:TMO) Stock Is Going Strong: Have Financials A Role To Play? - Yahoo Finance
Thermo Fisher Scientific authorizes share repurchases - Medical Buyer
United States Softgels Capsules Market Analysis 2025 | Industry - openPR.com
Thermo Fisher Scientific declares $0.43 quarterly dividend By Investing.com - Investing.com Nigeria
Thermo Fisher Scientific introduces the Helios MX1 PFIB-SEM - SelectScience
Thermo Fisher Scientific Inc (TMO) 財務データ
収益
当期純利益
現金流量
EPS
0.00%
1.65%
大文字化:
|
ボリューム (24 時間):